Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Explore affordable index funds for retirement and learn how low fees can boost your long-term gains. This intro covers selection basics and cost considerations.
23,808 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As institutional buyers step into Openlane, individual investors gain a front-row seat to a digitized used-vehicle ma...
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
Defense-tech pioneer Palmer Luckey calls for public-oversight over AI, arguing government power should guide how AI i...
Staying employed isn’t just about paychecks—it’s a powerful lever for real estate wealth. This guide shows how job st...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Quantum computing stocks ionq, Rigetti, and D-Wave have captured investor imaginations with big promises and big vola...
When the AI spotlight faded in April, some top names cooled off just enough to become bargains. This piece breaks dow...
Perella Weinberg stock lags the broader market, even as a major fund just boosted its stake by about $15 million. Thi...
A civil suit over a $100 million claim has escalated into a courtroom confrontation between Galaxy Digital founder Mi...
AI-driven productivity could redefine the path of interest rates. This article explores the mechanics, scenarios, and...
Microsoft stock sinking today has investors looking past a single bad headline. This deep-dive explains the drivers b...